How to Read a Certificate of Analysis

Every research-grade peptide should arrive with a certificate of analysis. Most researchers glance at it and file it. This is a mistake—not because most peptides fail their CoA, but because a CoA you can actually read is one of the most useful quality filters available, and reading it correctly takes less than five minutes once you know what to look for.

A certificate of analysis is an analytical document produced by a laboratory that characterizes a specific batch of compound. It tells you what the compound is, how pure it is, whether the structure is correct, and in some cases whether it is safe to inject. A CoA from a credible supplier performing credible tests provides meaningful assurance that you are working with what you think you are working with. A CoA from a supplier performing inadequate tests—or generating CoAs without actual testing—provides nothing, regardless of how professional it looks.

This guide explains each section of a research peptide CoA, what the numbers mean, what values are acceptable, what values should concern you, and what a CoA cannot tell you. The final section addresses how to evaluate supplier CoA practices—because the source of a CoA matters as much as its contents.

Anatomy of a Certificate of Analysis

A complete research peptide CoA contains several distinct sections, each reporting a different type of analytical test. Understanding what each section is testing—and what laboratory method generated the result—is the prerequisite for reading the numbers correctly.

The four core sections are: identity (mass spectrometry), purity (HPLC), endotoxin (LAL assay), and appearance. Not every supplier includes all four—which ones are present, and which tests were actually performed versus simply stated, is one of the key differentiators between credible and questionable CoA documentation.

HPLC Purity: What the Percentage Actually Means

HPLC stands for high-performance liquid chromatography. It is the standard analytical method for measuring peptide purity, and the purity percentage it reports is the single most important quantitative value on a research peptide CoA. Understanding what that percentage actually represents—and what it does not—changes how you interpret it.

How HPLC Works

In reverse-phase HPLC, the peptide sample is dissolved in solution and pumped under pressure through a column packed with hydrophobic beads (typically C18 silica). Different molecular species in the sample have different affinities for the hydrophobic stationary phase and travel through the column at different rates. As each species exits the column, it passes through a UV detector (typically set to 214–220 nm, where the peptide backbone absorbs). The detector records a signal peak for each species. The area under each peak is proportional to the amount of that species present.

The HPLC purity percentage is calculated as:

This means HPLC purity is a relative measurement—it tells you what fraction of the UV-absorbing material in the sample is your target peptide, not how much absolute peptide is present per unit weight. A 98% HPLC purity means 98% of the UV-detectable material is the correct peptide; the remaining 2% is other UV-absorbing species, which may include synthesis truncations, deletion sequences, oxidized variants, or other impurities from the manufacturing process.

What Purity Percentages Mean in Practice

For research-grade peptides intended for injection, 98% or greater purity is the standard. This is not an arbitrary number—at 98%+ purity, the impurity load is low enough that the unknown impurities are unlikely to produce significant biological effects at typical research doses. Below 95%, the impurity fraction is large enough to warrant concern: you are injecting a preparation that is 5% or more unknown compounds whose biological activity and safety are uncharacterized.

Peptide-grade purity tiers in practice: 95%+ is the minimum reasonable threshold for any research application; 98%+ is the standard for injectable use; 99%+ is what pharmaceutical-grade preparations target for clinical applications. Peptides labeled as “research grade” or “for laboratory use only” at 90% purity are below the appropriate threshold for injectable research use.

Reading the HPLC Chromatogram

Some CoAs include the actual HPLC chromatogram—the graphical output of the analysis showing signal intensity over time. If one is provided, the main peak (your target peptide) should be tall, sharp, and clearly dominant. Secondary peaks should be small and well-resolved from the main peak. A main peak with a broad, asymmetric shape (tailing) suggests either column overloading or a compound that does not elute cleanly—which can mean the purity percentage is less reliable. Multiple peaks of similar height to the main peak with a stated 98%+ purity should raise questions about how the calculation was performed.

Mass Spectrometry: Confirming Identity

Mass spectrometry (MS) confirms that the compound in the vial is the correct molecular species—that is, that it has the correct molecular weight consistent with the stated amino acid sequence. HPLC purity tells you how pure the sample is; mass spectrometry tells you that the main component is actually what it is supposed to be. Both tests are necessary; neither alone is sufficient.

How Mass Spectrometry Works

In mass spectrometry, the peptide is ionized (given an electrical charge) and then accelerated through a magnetic field. Ions of different mass-to-charge ratios (m/z) travel at different speeds and are detected separately. The output is a mass spectrum—a plot of signal intensity versus m/z—from which the molecular weight of the compound can be calculated precisely.

For peptides, the molecular weight measured by MS should match the theoretical molecular weight calculated from the amino acid sequence to within a small tolerance (typically ±0.1–1 Da depending on the MS instrument type and peptide size). A match confirms identity; a mismatch indicates either the wrong compound, a modification (such as incorrect oxidation state), or an analytical error.

Reading MS Data on a CoA

MS data on a CoA typically lists: the theoretical molecular weight (calculated from the sequence), the observed molecular weight (measured by MS), and a pass/fail result based on whether these match within the specified tolerance. It may also list the molecular formula and the ionization state(s) observed.

For peptides analyzed by electrospray ionization (ESI-MS)—the most common method for research peptide CoAs—multiply-charged ions are typically observed. The CoA may list m/z values for [M+2H]2+ or [M+3H]3+ species rather than the singly-charged [M+H]+ ion. This is normal and expected for peptides above approximately 10 amino acids. If the CoA provides m/z values for multiply-charged species, you can verify them with the formula: observed MW = (m/z × charge) − (charge × 1.008).

What MS Confirms and Does Not Confirm

Mass spectrometry confirms that the correct molecular weight species is present—it does not confirm that the peptide sequence is correct in every position, that the stereochemistry is correct (d- vs. l-amino acid isomers have the same molecular weight), or that modifications like acetylation or amidation at the termini are correct unless these are explicitly included in the theoretical MW calculation. For the vast majority of research peptide applications, correct MW is sufficient identity confirmation. For highly specialized applications where isomers or terminal modifications are critical, additional sequence confirmation (such as MS/MS fragmentation) may be required.

Endotoxin Testing: The Most Important Safety Test You’ve Never Heard Of

Endotoxin testing is the most safety-critical test on a research peptide CoA for injectable use, and it is also the most commonly absent. Understanding why it matters—and what its absence means—is essential for any injectable peptide research application.

The LAL Assay

The standard endotoxin test is the Limulus Amebocyte Lysate (LAL) assay, which uses a clotting enzyme from horseshoe crab blood that reacts specifically with bacterial endotoxin. The result is reported in endotoxin units per milligram (EU/mg) of compound. For injectable pharmaceutical preparations, the general threshold is 5 EU/kg body weight per hour for most routes and indications. For a typical research dose of a few hundred micrograms, this translates to an acceptable endotoxin level of approximately 5 EU/mg or less in the bulk compound.

A CoA that reports endotoxin at <1 EU/mg or <5 EU/mg with a LAL assay result is providing meaningful safety data. A CoA that does not include endotoxin testing—or states “endotoxin: not tested”—is providing no safety data on this critical parameter.

Why Many Supplier CoAs Lack Endotoxin Data

LAL testing is significantly more expensive and technically demanding than HPLC or basic MS analysis. Many research peptide suppliers—particularly those operating at lower cost points or without pharmaceutical-grade production infrastructure—do not routinely test for endotoxin. This is a real quality control gap, not a trivial omission. The consequences of injecting endotoxin-contaminated material range from a local inflammatory reaction indistinguishable from an infection to a systemic febrile response that could be misattributed to the peptide compound itself.

For any peptide intended for injection, a supplier that does not provide endotoxin data should either be asked for it explicitly (some will test on request) or evaluated critically against suppliers who do include it as standard. The absence of endotoxin testing does not mean the material is contaminated—it means you have no data on this critical parameter.

Other Tests: Sterility, Water Content, and Appearance

Sterility Testing

Sterility testing confirms the absence of viable microorganisms in the final product. It is distinct from endotoxin testing: a preparation can be sterile (no live bacteria) but still contain endotoxin (bacterial breakdown products from dead bacteria are not removed by sterilization processes). Sterility testing is the standard for pharmaceutical injectable preparations but is rarely performed on research-grade peptides, which are typically not produced under pharmaceutical sterile manufacturing conditions.

The absence of a sterility test on a research peptide CoA is the norm, not the exception. Research peptides are generally not sterile products—they are synthesized, purified, and lyophilized under conditions that reduce but may not eliminate microbial contamination. This is why aseptic reconstitution technique (sterile solvents, sterile needles, alcohol-swabbed stoppers) and the use of bacteriostatic water are important downstream controls.

Water Content (Karl Fischer Titration)

Lyophilized peptide vials contain some residual moisture even after freeze-drying—typically 1–5% by weight. Water content is measured by Karl Fischer titration, a volumetric method specific for water. High residual moisture (>5%) indicates incomplete lyophilization and predicts faster degradation in storage.

Water content data on a CoA is useful but not always present. When it is reported, values below 5% are acceptable; values above 8% suggest lyophilization quality issues worth noting.

Appearance

Appearance is the simplest test—a visual inspection of the lyophilized material that confirms it is the correct physical form (white to off-white lyophilized powder or cake), free from visible particulates or unusual color. Appearance does not require specialized equipment; it is a basic quality confirmation that the product arrived in the expected state.

Batch Numbers, Dates, and Traceability

A legitimate CoA is specific to a particular batch of compound. The batch number (also called lot number) on the CoA should match the batch number on the product label. This traceability is what makes a CoA meaningful: a generic CoA that lists impressive analytical results but is not tied to a specific lot number provides no assurance about the specific vial you received.

Check that the CoA lists: a specific lot/batch number that matches your vial label; an analysis date (the date the analytical testing was performed); a product name and specification that matches what you ordered; and a stated testing laboratory (either in-house or a third-party analytical lab).

The analysis date matters because CoA testing is performed at a specific point in time—it characterizes the compound as it existed when tested, not necessarily at the time you receive or use it. A CoA dated 18 months ago on a product that has been stored poorly since testing does not guarantee current quality.

Evaluating Supplier CoA Practices

The value of a CoA depends entirely on the analytical practices behind it. A professionally formatted document with high-looking numbers means nothing if the testing was not actually performed, performed incorrectly, or performed on a different lot than what was shipped to you.

Third-Party Testing vs. In-House Testing

The most credible CoA documentation comes from independent third-party analytical laboratories—organizations with no commercial interest in the result. An in-house CoA from the supplier’s own laboratory is not worthless, but it carries a potential conflict of interest: a supplier who tests their own products and reports the results has more incentive to produce favorable numbers than an independent lab does.

Some suppliers provide both in-house and third-party CoA data; this is the gold standard. Third-party CoAs should name the testing laboratory and ideally include the laboratory’s own letterhead or certificate number, allowing independent verification that the lab exists and performed the test.

What Good Supplier CoA Practice Looks Like

A reputable supplier of research-grade injectable peptides should: provide a lot-specific CoA with every order; include both HPLC purity and MS identity confirmation; ideally include endotoxin testing; provide CoAs on request before purchase; and be willing to answer questions about their testing methodology and laboratory identity. Suppliers who provide generic CoAs not tied to specific lots, who cannot or will not identify their testing laboratory, or who resist questions about their analytical methods should be evaluated with appropriate skepticism.

Red Flags: When to Question a CoA

Red Flag	What It May Indicate
No lot/batch number on the CoA	Generic document not specific to your order; no meaningful traceability
Purity stated as “≥99%” but no chromatogram or area data provided	Number may be unverified; legitimate HPLC results include area percentages or a chromatogram
MS result shows “molecular weight confirmed” without listing observed vs. theoretical MW values	Unverifiable claim; legitimate MS results list actual m/z data
Testing laboratory not named or identifiable	Cannot verify testing was actually performed by an independent party
CoA lot number does not match vial label	CoA may be for a different batch than what you received; not applicable to your product
Identical CoA provided for different compounds from the same supplier	Template CoA, not compound-specific; no real analytical data
HPLC purity listed as exactly 99.0% or 98.0% across many different products	Round numbers suggest results may not reflect actual measurements; real HPLC data rarely lands exactly on round numbers

What a CoA Cannot Tell You

A CoA, even a high-quality one, has real limitations that should shape how much confidence you place in it.

A CoA does not guarantee biological activity. A peptide can be 99% pure with confirmed correct molecular weight and still be biologically inactive if it has been degraded in a way that does not change its molecular weight—for example, oxidation of a methionine residue to methionine sulfoxide changes the biology without changing the molecular weight detectably by standard MS. Purity and identity are necessary but not sufficient conditions for biological activity.

A CoA characterizes a specific lot at a specific point in time. The analytical results reflect the compound as it was when tested. Storage degradation after testing is not captured by the CoA. A CoA from a year ago on material that has been stored improperly since then does not describe the current state of the compound.

A CoA does not test for all possible impurities. HPLC purity measures UV-absorbing species at a specific wavelength. Impurities that do not absorb strongly at that wavelength may be present but not detected. Residual solvents from the synthesis process, metal contaminants from equipment, and non-UV-absorbing chemical species can all be present without appearing in the HPLC purity calculation.

A CoA cannot confirm that the compound will behave as documented in published research. Even a perfectly characterized compound may behave differently in your specific research context due to differences in preparation, administration, and biological variables. This is particularly true for compounds where the published research used different formulations or delivery systems than what is commercially available.

Frequently Asked Questions

What is the minimum acceptable HPLC purity for research peptides?

For any injectable application, 98% or greater is the standard. Below 95% represents a meaningful impurity load that introduces unknown variables into any research application. Peptides at 90% purity or below are not appropriate for injectable research use, regardless of how they are marketed.

My supplier doesn’t test for endotoxin. Should I be concerned?

Yes, for injectable use. Endotoxin testing is the critical safety gap in many research peptide CoAs. The absence of endotoxin data means you have no information about whether the material is safe to inject from a contamination standpoint. For suppliers that do not routinely test for endotoxin, it is reasonable to ask whether testing can be performed on request, or to evaluate suppliers who do include it as standard practice. For non-injectable applications (topical, in vitro research), the endotoxin concern is substantially reduced.

Can I verify a CoA myself?

You can verify some aspects independently. You can check whether the theoretical molecular weight on the CoA matches the expected molecular weight calculated from the amino acid sequence—this calculation is straightforward with free online tools. You can check whether the testing laboratory named on the CoA is a real, identifiable analytical laboratory. You can check whether the lot number matches your vial. You cannot independently verify the actual analytical measurements without access to analytical equipment, but verifying these basic traceability elements catches the most common CoA quality issues.

Is third-party testing always better than in-house testing?

Third-party testing eliminates the supplier’s conflict of interest, which is a meaningful quality consideration. However, a reputable supplier with rigorous in-house quality control and transparent methodology can produce reliable data, while a supplier with poor-quality third-party testing can produce meaningless results. Third-party testing from a named, verifiable analytical laboratory is a positive quality signal. Third-party testing from an unidentifiable or unverifiable laboratory provides no additional assurance over in-house testing.